As of June 30, 2024, Inoviq Ltd carries a market capitalization of 59.09M, placing it among publicly traded companies globally. Its enterprise value stands at 50.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 59.09M |
| Enterprise Value | 50.26M |
Inoviq Ltd's next confirmed earnings release is scheduled for February 19, 2027.
| Earnings Date | 2/19/2027 |
As of June 30, 2024, Inoviq Ltd has 105.52M shares outstanding.
| Shares Outstanding | 105.52M |
These figures are as of June 30, 2024. The price-to-sales ratio is 96.72, and the price-to-book ratio stands at 2.96.
| PS Ratio | 96.72 |
| PB Ratio | 2.96 |
| P/TBV Ratio | 5.75 |
These figures are as of June 30, 2024. The EV/Sales ratio of 93.93 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 50.26M versus a market cap of 59.09M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 93.93 |
As of June 30, 2024, Inoviq Ltd maintains a current ratio of 7.07, meaning it holds 7.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 7.07 |
| Quick Ratio | 6.85 |
| Debt / Equity | 2.02 |
| Debt / EBITDA | -0.06 |
Over the twelve months ended June 30, 2024, Inoviq Ltd posted a negative return on equity (ROE) of -33.10, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -30.33, reflecting losses generated across the asset base. Inventory turnover of 4.55 indicates how many times Inoviq Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -33.10 |
| Return on Assets (ROA) | -30.33 |
| Inventory Turnover | 4.55 |
As of the close on October 21, 2026, Inoviq Ltd's stock has declined approximately 62.32% over the past 52 weeks. The 50-day moving average sits at 0.17, while the 200-day moving average is 0.28.
| 52-Week Price Change | -62.32% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.28 |
Over the twelve months ended June 30, 2024, Inoviq Ltd generated 535,118.00 in revenue and converted that into -6.55M in net income, yielding earnings per share of -0.07. EBITDA reached -6.63M, while operating income came in at -7.84M.
| Revenue | 535,118.00 |
| Gross Profit | 454,105.00 |
| Operating Income | -7.84M |
| Pretax Income | -6.55M |
| Net Income | -6.55M |
| EBITDA | -6.63M |
| EBIT | -7.84M |
| Earnings Per Share (EPS) | -0.07 |
As of June 30, 2024, Inoviq Ltd holds 9.23M in cash and equivalents against 403,735.00 in total debt, resulting in a net debt position of -9.23M. Total book value stands at 19.99M, with working capital of 9.32M providing operational flexibility.
| Cash & Cash Equivalents | 9.23M |
| Total Debt | 403,735.00 |
| Net Debt | -9.23M |
| Equity (Book Value) | 19.99M |
| Book Value Per Share | 0.19 |
| Working Capital | 9.32M |
These figures cover the twelve months ended June 30, 2024.
| Capital Expenditures | -174,337.00 |
Over the twelve months ended June 30, 2024, Inoviq Ltd posted a gross margin of 84.86, reflecting its pricing power and cost economics. The operating margin of -1,464.61 and net profit margin of -1,224.84 provide insight into operational efficiency.
| Gross Margin | 84.86 |
| Operating Margin | -1,464.61 |
| Pretax Margin | -1,224.84 |
| Profit Margin | -1,224.84 |
| EBITDA Margin | -1,239.61 |
These figures cover the twelve months ended June 30, 2024. Total shareholder yield is negative at -10.01, meaning Inoviq Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -10.01 |
Inoviq Ltd's most recent stock split took place on December 7, 2020 with a 30:1 split ratio.
| Last Split Date | 12/7/2020 |
| Split Ratio | 30:1 |
As of June 30, 2024, Inoviq Ltd has an Altman Z-Score of 12.80, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 12.80 |
Already premium?